Wells Fargo’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Wells Fargo’s Portfolio DRTX Stock Details DRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-13,360	Closed	-$170K	–	6697
2014 Q3	$170K	Sell	13,360 -3,149	-19%	-$47K	﹤0.01%	4427
2014 Q2	$281K	Buy	16,509 +16	+0.1%	+$238	﹤0.01%	4214
2014 Q1	$222K	Buy	+16,493	New	+$216K	﹤0.01%	4287

Wells Fargo's DRTX Position: Q4 2014 in Review

Wells Fargo sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 13,360 shares — an estimated $170K sold.

Wells Fargo first reported a position in DRTX in Q1 2014 and held it in 3 quarters. The position peaked at $281K in Q2 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

Wells Fargo reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
Wells Fargo sold 13,360 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $170K.
Wells Fargo first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q1 2014 and held it in 3 quarters.
Wells Fargo's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $281K in Q2 2014.
0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Wells Fargo's 13F filing for Q4 2014, filed 11 Feb 2015.